Technology
Health
Medical

LivaNova

$72.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.91 (1.28%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell LivaNova and other stocks, options, ETFs, and crypto commission-free!

About

LivaNova PLC Ordinary Shares, also called LivaNova, is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular, Neuromodulation, and Others. Read More The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The Other segment consists of company's shared service expenses for finance, legal, human resources, information technology, and new ventures. Its products include VNS therapy system. oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, and cannulae. The company was founded on October 19, 2015 and is headquartered in London, the United Kingdom.

Employees
4,000
Headquarters
London, Greater London
Founded
2015
Market Cap
3.49B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
538.51K
High Today
$72.46
Low Today
$71.51
Open Price
$71.51
Volume
112.85K
52 Week High
$131.54
52 Week Low
$64.80

Collections

Technology
Health
Medical
Healthcare
Medical Devices
Finance
Information Technology
Therapy

News

TradingNewsNowMay 8

Present Fundamentals: LivaNova (NASDAQ: LIVN)

LivaNova is part of the healthcare sector and is in the medical devices industry. The company CEO is Damien McDonald. LivaNova is a medical technology company formed by the merger of Sorin S.p.A, engaged in the treatment of cardiovascular diseases, and Cyberonics, a medical device company with core expertise in neuromodulation. Previous Intraday Trading Performance: The LIVN stock showed a previous change of -3.82% with an open at 73.97 and a close of 72.09. It reached an intraday high of 74.92 and a low ...

48
Seeking AlphaMay 5

LivaNova PLC (LIVN) CEO Damien McDonald on Q1 2019 Results - Earnings Call Transcript

LivaNova PLC (NASDAQ:LIVN) Q1 2019 Results Earnings Conference Call May 1, 2019 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development Damien McDonald - Chief Executive Officer Thad Huston - Chief Financial Officer Melissa Farina - Vice President of Investor Relations Conference Call Participants Raj Denhoy - Jefferies LLC Rick Wise - Stifel Matthew O'Brien - Piper Jaffray Scott Bardo - Berenberg Matthew Taylor - UBS Michael Matson - Needham & Company, LLC ...

65
Markets InsiderMay 3

New Data Emphasizing LivaNova Perceval Valve Durability to be Presented at the American Association for Thoracic Surgery Meeting

Livanova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that new clinical data for its sutureless surgical aortic valve, Perceval®, will be unveiled at this year’s American Association for Thoracic Surgery (AATS) meeting.

56

Earnings

$0.54
$0.73
$0.93
$1.12
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Jul 31, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.